Debate: Adjuvant whole brain radiotherapy or not? More data is the wiser choice

BMC Cancer

Volumn 16, Issue 1, 2016, Pages

  Fogarty, Gerald B ^a,b,c,d,j   Hong, Angela ^a,b,c   Gondi, Vinai ^g,h   Burmeister, Bryan ^c,d,e   Jacobsen, Kari ^f   Lo, Serigne ^a,b,c   Paton, Elizabeth ^b,c   Shivalingam, Brindha ⁱ   Thompson, John F ^a,b,c  

^a MELANOMA INSTITUTE AUSTRALIA   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Australia and New Zealand Gynaecological Oncology Group   (Australia)

^d Trans Tasman Radiation Oncology Group   (Australia)

^e PRINCESS ALEXANDRA HOSPITAL   (Australia)

^f OSLO UNIVERSITY HOSPITAL   (Norway)

^g CENTRAL DUPAGE HOSPITAL   (United States)

^h UNIVERSITY OF WISCONSIN   (United States)

ⁱ ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^j Mater Sydney Radiation Oncology   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT WHOLE BRAIN RADIOTHERAPY; ARTICLE; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COGNITION; HUMAN; MELANOMA; OVERALL SURVIVAL; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEREOTAXIC SURGERY; ADJUVANT RADIOTHERAPY; BRAIN NEOPLASMS; FEMALE; MALE; MEDICAL SOCIETY; ORGANIZATION AND MANAGEMENT; PROCEDURES; RADIOSURGERY; SECONDARY; TREATMENT OUTCOME;

BRAIN NEOPLASMS; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOCIETIES, MEDICAL; TREATMENT OUTCOME;

EID: 84976905149     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-016-2433-8     Document Type: Article

References (23)

1. Platta CS, Khuntia D, Mehta MP, et al. Current treatment strategies for brain metastasis and complications from therapeutic techniques: a review of current literature. Am J Clin Oncol. 2010;33(4):398-407.
2. ASTRO releases second list of five radiation oncology treatments to question, as part of national Choosing Wisely® campaign. 2014. www.choosingwisely.org/astro-releases-second-list. Accessed 1 July 2016.
3. Stouten-Kemperman MM, de Ruiter MB, Koppelmans V, et al. Neurotoxicity in breast cancer survivors ≥10 years post-treatment is dependent on treatment type. Brain Imaging Behav. 2015;9(2):275-84.
4. Brown P, Asher AA, Ballman K, et al. NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases. 2015 ASCO Annual Meeting; 2015. http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/LBA4. Accessed 1 July 2016.
5. Sahgal A, Larson D, Knisely J. Stereotactic radiosurgery alone for brain metastases. Lancet Oncol. 2015;16(3):249-50.
6. Sahgal A, Aoyama H, Kocher M, et al. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys. 2015;91(4):710-7.
7. Arvold ND, Catalano PJ. Local therapies for brain metastases, competing risks, and overall survival. Int J Radiat Oncol Biol Phys. 2015;91(4):718-20.
8. Moher D, Liberati A, Tetzlaff J, The PRISMA Group, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 6(7):e1000097. doi: 10.1371/journal.pmed.1000097. Accessed 1 July 2016.
9. Higgins JPT, Green S (editors): Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. Accessed 1 July 2016.
10. Higgins JPT, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
11. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295:2483-91.
12. Aoyama H, Tago M, Shirato H. Stereotactic radiosurgery with or without whole-brain radiotherapy for brain metastases: secondary analysis of the JROSG 99-1 randomized clinical trial. JAMA Oncol. 2015;1(4):457-64. doi: 10.1001/jamaoncol.2015.1145.
13. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010;77:655-61.
14. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10:1037-44.
15. Gondi V, Pugh SL, Tome WA, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. J Clin Oncol. 2014;32(34):3810-6.
16. Du Four S, Hong A, Chan M, et al. Symptomatic histologically proven necrosis of brain following stereotactic radiation and ipilimumab in six lesions in four melanoma patients. Case Rep Oncol Med. 2014;2014:417913.
17. Lim SH, Lee JY, Lee MY, et al. A randomized phase III trial of stereotactic radiosurgery (SRS) versus observation for patients with asymptomatic cerebral oligo-metastases in non-small-cell lung cancer. Ann Oncol. 2015;26(4):762-8.
18. Fogarty G, Morton RL, Vardy J, et al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients-a randomised phase III trial. BMC Cancer. 2011;11:142.
19. Fogarty GB, Hong A, Dolven-Jacobsen K, et al. First interim analysis of a randomised trial of whole brain radiotherapy in melanoma brain metastases confirms high data quality. BMC Res Notes. 2015;8(1):192.
20. Hamilton DW, de Salis I, Donovan JL, et al. The recruitment of patients to trials in head and neck cancer: a qualitative study of the EaStER trial of treatments for early laryngeal cancer. Eur Arch Otorhinolaryngol. 2013;270(8):2333-7.
21. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485-9.
22. Roos DE, Smith JG, Stephens SW. Radiosurgery versus surgery, both with adjuvant whole brain radiotherapy, for solitary brain metastases: a randomised controlled trial. Clin Oncol (R Coll Radiol). 2011;23(9):646-51.
23. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol. 2011;29:134-41.